{"title":"Preface: New Immunological Approaches to Cancer Therapy Dedicated to Dr. Michio Nishida","authors":"R. Newman","doi":"10.1615/forumimmundisther.2015014036","DOIUrl":"https://doi.org/10.1615/forumimmundisther.2015014036","url":null,"abstract":"","PeriodicalId":89370,"journal":{"name":"Forum on immunopathological diseases and therapeutics","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1615/forumimmundisther.2015014036","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67440248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Preface: Advances in Molecular Targets for Therapeutics in Resistant Cancers","authors":"M. Cervello, N. D’alessandro","doi":"10.1615/FORUMIMMUNDISTHER.2015014075","DOIUrl":"https://doi.org/10.1615/FORUMIMMUNDISTHER.2015014075","url":null,"abstract":"","PeriodicalId":89370,"journal":{"name":"Forum on immunopathological diseases and therapeutics","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1615/FORUMIMMUNDISTHER.2015014075","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67440306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Immunocytokines for Cancer Therapy","authors":"P. Probst, D. Neri","doi":"10.1615/FORUMIMMUNDISTHER.2015014013","DOIUrl":"https://doi.org/10.1615/FORUMIMMUNDISTHER.2015014013","url":null,"abstract":"","PeriodicalId":89370,"journal":{"name":"Forum on immunopathological diseases and therapeutics","volume":"5 1","pages":"83-99"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67440134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. D’alessandro, M. Labbozzetta, N. Vivona, M. N. D. Villarosa, P. Poma, M. Notarbartolo
{"title":"Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors","authors":"N. D’alessandro, M. Labbozzetta, N. Vivona, M. N. D. Villarosa, P. Poma, M. Notarbartolo","doi":"10.1615/FORUMIMMUNDISTHER.2015013936","DOIUrl":"https://doi.org/10.1615/FORUMIMMUNDISTHER.2015013936","url":null,"abstract":"","PeriodicalId":89370,"journal":{"name":"Forum on immunopathological diseases and therapeutics","volume":"5 1","pages":"215-222"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67439451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. Donnini, Federica Finetti, E. Terzuoli, L. Bazzani, M. Ziche
{"title":"Targeting PGE2 Signaling in Tumor Progression and Angiogenesis.","authors":"S. Donnini, Federica Finetti, E. Terzuoli, L. Bazzani, M. Ziche","doi":"10.1615/FORUMIMMUNDISTHER.2015014095","DOIUrl":"https://doi.org/10.1615/FORUMIMMUNDISTHER.2015014095","url":null,"abstract":"","PeriodicalId":89370,"journal":{"name":"Forum on immunopathological diseases and therapeutics","volume":"30 1","pages":"223-232"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67439864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Rituxan: The First 20 Years","authors":"R. Newman","doi":"10.1615/FORUMIMMUNDISTHER.2015013931","DOIUrl":"https://doi.org/10.1615/FORUMIMMUNDISTHER.2015013931","url":null,"abstract":"","PeriodicalId":89370,"journal":{"name":"Forum on immunopathological diseases and therapeutics","volume":"5 1","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67439442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. Nobili, R. Tassi, I. Landini, G. Perrone, C. Napoli, E. Mini
{"title":"Druggable Targets in Pancreatic Adenocarcinoma","authors":"S. Nobili, R. Tassi, I. Landini, G. Perrone, C. Napoli, E. Mini","doi":"10.1615/FORUMIMMUNDISTHER.2015014118","DOIUrl":"https://doi.org/10.1615/FORUMIMMUNDISTHER.2015014118","url":null,"abstract":"Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related death worldwide. It is often diagnosed at an advanced or metastatic stage and results of the approved systemic therapies are discouraging, making PDAC one of most lethal cancers in Western countries. In recent years, a better comprehension of PDAC unique biology has disclosed new potential targets for therapeutic interventions. Meanwhile, the development of conjugated agents, small molecules, antibodies, and immunoagents has opened therapeutic opportunities for drugs able to exert therapeutic effects on druggable targets of PDAC biology. Despite some failures, this approach is bringing meaningful results from bench to bedside, and more efficacious therapeutic opportunities may become available for PDAC treatment. In this review, we discuss the main hallmarks of PDAC biology as its microenvironment, cancerdriving proliferative pathways, growth suppression loops, and how PDAC evades immune system surveillance, as well as molecular aspects of each feature. The main preclinical and clinical results of each targeted intervention are also presented considering its biological rationale. Ongoing clinical trials provide evidence of the effectiveness of this approach and promising results in the treatment of PDAC.","PeriodicalId":89370,"journal":{"name":"Forum on immunopathological diseases and therapeutics","volume":"5 1","pages":"195-214"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1615/FORUMIMMUNDISTHER.2015014118","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67439911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Preface: NF-κB, Immune System and Chronic Diseases: How Are They Linked?","authors":"Subash C. Gupta, B. Aggarwal","doi":"10.1615/FORUMIMMUNDISTHER.2013008395","DOIUrl":"https://doi.org/10.1615/FORUMIMMUNDISTHER.2013008395","url":null,"abstract":"","PeriodicalId":89370,"journal":{"name":"Forum on immunopathological diseases and therapeutics","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1615/FORUMIMMUNDISTHER.2013008395","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67439769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Molecular Targets for Suppression of Metastasis: Recent Cellular Observations","authors":"S. Simizu, Y. Niwa","doi":"10.1615/FORUMIMMUNDISTHER.2013008306","DOIUrl":"https://doi.org/10.1615/FORUMIMMUNDISTHER.2013008306","url":null,"abstract":"","PeriodicalId":89370,"journal":{"name":"Forum on immunopathological diseases and therapeutics","volume":"4 1","pages":"43-51"},"PeriodicalIF":0.0,"publicationDate":"2013-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67439529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}